These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37112969)

  • 1. The Flavonoid Cyanidin Shows Immunomodulatory and Broad-Spectrum Antiviral Properties, Including SARS-CoV-2.
    Vicente J; Benedetti M; Martelliti P; Vázquez L; Gentilini MV; Peñaranda Figueredo FA; Nabaes Jodar MS; Viegas M; Barquero AA; Bueno CA
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aesculus hippocastanum extract and the main bioactive constituent β-escin as antivirals agents against coronaviruses, including SARS-CoV-2.
    Peñaranda Figueredo FA; Vicente J; Barquero AA; Bueno CA
    Sci Rep; 2024 Mar; 14(1):6418. PubMed ID: 38494515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.
    Ma Q; Pan W; Li R; Liu B; Li C; Xie Y; Wang Z; Zhao J; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Yang Z
    Pharmacol Res; 2020 Aug; 158():104850. PubMed ID: 32360580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.
    Ma Q; Wang Z; Chen R; Lei B; Liu B; Jiang H; Chen Z; Cai X; Guo X; Zhou M; Huang J; Li X; Dai J; Yang Z
    Phytomedicine; 2022 Jan; 95():153874. PubMed ID: 34923232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liu Shen Wan inhibits influenza a virus and excessive virus-induced inflammatory response via suppression of TLR4/NF-κB signaling pathway in vitro and in vivo.
    Ma Q; Huang W; Zhao J; Yang Z
    J Ethnopharmacol; 2020 Apr; 252():112584. PubMed ID: 31972325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad antiviral and anti-inflammatory activity of Qingwenjiere mixture against SARS-CoV-2 and other human coronavirus infections.
    Xie P; Fang Y; Shen Z; Shao Y; Ma Q; Yang Z; Zhao J; Li H; Li R; Dong S; Wen W; Xia X
    Phytomedicine; 2021 Dec; 93():153808. PubMed ID: 34753027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of Anti-apoptotic Bcl-2 Family Proteins Exhibit Potent and Broad-Spectrum Anti-mammarenavirus Activity via Cell Cycle Arrest at G0/G1 Phase.
    Kim YJ; Witwit H; Cubitt B; de la Torre JC
    J Virol; 2021 Nov; 95(24):e0139921. PubMed ID: 34586865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo effects of 3-indoleacetonitrile-A potential new broad-spectrum therapeutic agent for SARS-CoV-2 infection.
    Hui X; Yu X; Huang K; Xu T; Cao L; Zhang Y; Zhao L; Zhao Y; Lv C; Feng S; Jiang Y; Liu L; Jin M
    Antiviral Res; 2023 Jan; 209():105465. PubMed ID: 36402240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and Toll-like receptor signalling.
    Ling LJ; Lu Y; Zhang YY; Zhu HY; Tu P; Li H; Chen DF
    Phytomedicine; 2020 Feb; 67():153150. PubMed ID: 31958713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter to the Editor in response to the articles 'Lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2)' and 'Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.'.
    Huang X; Zhao Q; Xia L; Shi S
    Pharmacol Res; 2021 Jan; 163():105289. PubMed ID: 33197600
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication
    Shytaj IL; Fares M; Gallucci L; Lucic B; Tolba MM; Zimmermann L; Adler JM; Xing N; Bushe J; Gruber AD; Ambiel I; Taha Ayoub A; Cortese M; Neufeldt CJ; Stolp B; Sobhy MH; Fathy M; Zhao M; Laketa V; Diaz RS; Sutton RE; Chlanda P; Boulant S; Bartenschlager R; Stanifer ML; Fackler OT; Trimpert J; Savarino A; Lusic M
    mBio; 2022 Apr; 13(2):e0370521. PubMed ID: 35229634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
    Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K
    Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macromolecular Viral Entry Inhibitors as Broad-Spectrum First-Line Antivirals with Activity against SARS-CoV-2.
    Groß R; Dias Loiola LM; Issmail L; Uhlig N; Eberlein V; Conzelmann C; Olari LR; Rauch L; Lawrenz J; Weil T; Müller JA; Cardoso MB; Gilg A; Larsson O; Höglund U; Pålsson SA; Tvilum AS; Løvschall KB; Kristensen MM; Spetz AL; Hontonnou F; Galloux M; Grunwald T; Zelikin AN; Münch J
    Adv Sci (Weinh); 2022 Jul; 9(20):e2201378. PubMed ID: 35543527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro.
    Ma Q; Lei B; Chen R; Liu B; Lu W; Jiang H; Chen Z; Guo X; Wang Y; Zhang L; Chen Q; Li X; Yang Z
    Chin Med; 2022 Apr; 17(1):40. PubMed ID: 35365215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
    Patil AM; Göthert JR; Khairnar V
    Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of a broad range of SARS-CoV-2 variants by antiviral phytochemicals in hACE2 mice.
    Kim EH; Lee BW; Ryu B; Cho HM; Kim SM; Jang SG; Casel MAB; Rollon R; Yoo JS; Poo H; Oh WK; Choi YK
    Antiviral Res; 2022 Aug; 204():105371. PubMed ID: 35777669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19.
    Demarest JF; Kienle M; Boytz R; Ayres M; Kim EJ; Patten JJ; Chung D; Gandhi V; Davey RA; Sykes DB; Shohdy N; Pottage JC; Kumar VS
    Antiviral Res; 2022 Oct; 206():105403. PubMed ID: 36041646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.